Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Price

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Magnetic Resonance Imaging|January 1, 1985
The use of Gd DTPA as a perfusion agent and marker of blood-brain barrier disruptionV M Runge, J A Clanton, A C Price, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 1, 1992
High-dose gadoteridol in MR imaging of intracranial neoplasmsV M Runge, J E Kirsch, V J Burke, et al.
Physiological Chemistry and Physics and Medical NMR|January 1, 1984
Paramagnetic contrast agents in magnetic resonance imaging: research at Vanderbilt UniversityV M Runge, J A Clanton, A C Price, et al.
Southern Medical Journal|May 1, 1985
Current status of magnetic resonance imagingA E James, C L Partain, J A Patton, et al.
AJNR. American Journal of Neuroradiology|June 1, 1994
Phase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastasesW T Yuh, D J Fisher, V M Runge, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|January 1, 1988
Gd DTPA. Clinical efficacyV M Runge, T F Schaible, H A Goldstein, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Magnetic Resonance Imaging|January 1, 1985
The use of Gd DTPA as a perfusion agent and marker of blood-brain barrier disruptionV M Runge, J A Clanton, A C Price, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 1, 1992
High-dose gadoteridol in MR imaging of intracranial neoplasmsV M Runge, J E Kirsch, V J Burke, et al.
Physiological Chemistry and Physics and Medical NMR|January 1, 1984
Paramagnetic contrast agents in magnetic resonance imaging: research at Vanderbilt UniversityV M Runge, J A Clanton, A C Price, et al.
Southern Medical Journal|May 1, 1985
Current status of magnetic resonance imagingA E James, C L Partain, J A Patton, et al.
AJNR. American Journal of Neuroradiology|June 1, 1994
Phase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastasesW T Yuh, D J Fisher, V M Runge, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|January 1, 1988
Gd DTPA. Clinical efficacyV M Runge, T F Schaible, H A Goldstein, et al.
Pageof 4